Dong Xie

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

Roy S. Herbst, David H. Johnson, Eric D. Mininberg et al. · Journal of Clinical Oncology · 2005 · 536 citations · Full text

Medicine, Oncology, Pharmacology +16

Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway

Wei Liu, Muyu Yu, Dong Xie et al. · Stem Cell Research & Therapy · 2020 · 506 citations · Full text

Veterinary Medicine, Biomedical Sciences, Cell Biology +16

Development and Validation of a Deep Learning Model for Non–Small Cell Lung Cancer Survival

Yunlang She, Zhuochen Jin, Junqi Wu et al. · JAMA Network Open · 2020 · 273 citations · Full text

Medicine, Oncology, Precision Medicine +14

Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study

Chenyang Dai, Jianfei Shen, Yijiu Ren et al. · Journal of Clinical Oncology · 2016 · 245 citations

Medicine, Oncology, Surgery +15

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1

Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang et al. · Neuro-Oncology · 2006 · 219 citations · Full text

Medicine, Oncology, Pharmacology +17